Amara Taps Capsule Tech as Exclusive Reseller of Clinical Vigilance™ for Sepsis Software

Partnership will deliver predictive analytics fed by real-time data.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

San Diego, CA (PRWEB) April 17, 2014

Amara Health Analytics, Inc. today announced that it has selected Capsule Tech, Inc. as the exclusive North America reseller of Amara’s Clinical Vigilance™ for Sepsis product, the industry’s most accurate decision support software for aiding providers in the early identification of hospital patients at risk of sepsis. Capsule will offer Clinical Vigilance for Sepsis as part of its recently introduced SmartLinx Medical Device Information System (MDIS), the industry’s first MDIS. Capsule has been the leading global provider of medical device integration solutions to hospitals for over a decade.

"Capsule's SmartLinx system is a perfect complement to Clinical Vigilance for Sepsis because the real-time data feed from SmartLinx, combined with the other hundred-plus clinical variables in our predictive model, enables Clinical Vigilance to send alerts to hospital staff at the earliest possible moment," said Steve Nathan, chief executive officer at Amara. "Capsule's current presence in over 1,650 hospitals in 37 countries, and its reach to many more, makes it an excellent avenue for putting Clinical Vigilance in a position to help clinicians in managing sepsis."

Sepsis has been declared a global medical emergency by the Global Sepsis Alliance (GSA), with Konrad Reinhart, M.D., Chairman of the GSA, noting that "Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide." In the U.S., according to the latest data from the Agency for Healthcare Research and Quality (AHRQ), there are over 800,000 cases of sepsis annually, resulting in high mortality and a cost of over $20 billion to the healthcare system.

"Extensive research has shown that early identification of sepsis is key to successful outcomes and lower hospital costs," said Susan Niemeier, RN, chief nursing officer at Capsule. "Clinical Vigilance for Sepsis supports clinicians in very early identification and, just as important, its extremely high accuracy avoids the alarm fatigue that can occur with other hospital alerting systems."

"Our approach to predictive analytics benefits from as much raw data as possible," said Dr. Christopher Rosin, Amara's chief scientist. "For example, we get important signal by applying deep natural language processing to clinical text, and we use machine learning to intelligently filter the physiological data streams from SmartLinx. We're excited about our partnership with Capsule because of the importance of timely monitoring of data to delivering to hospitals the best results from Clinical Vigilance for Sepsis."

Amara, Capsule, and Dr. Ryan Arnold of Christiana Care Health System will discuss "Using Predictive Analytics to Improve Sepsis Outcomes" at the New York Health Information and Management Systems Society (HIMSS) Chapter conference on April 23 at the Marriott Marquis in New York City.

About Amara
Amara Health Analytics provides high-accuracy predictive clinical analytics software driven by a unique combination of machine learning, natural language processing, semantic analysis, and real-time physiological signal processing. The Amara team represents decades of success in helping hospitals, biomedical research institutions, and other enterprises achieve their goals by exploiting breakthrough technologies. Visit http://www.amarahealthanalytics.com.

About Capsule
Capsule is the leading global provider of medical device integration solutions for hospitals and healthcare organizations. Capsule’s SmartLinx Medical Device Information System (MDIS) increases efficiency and improves patient care through the systematic real-time capture of patient vitals at the point-of-care and the delivery of those data to hospital electronic medical records, other information systems and third party mobile solutions. Powerful clinical surveillance and analytical software tools enable alarms and alerts to clinicians of adverse patient conditions, allowing timely patient interventions. Capsule’s solutions are flexible and scalable, offering a variety of deployment options to meet the needs of any healthcare delivery organization. Founded in 1997, the Company has established strong partnerships with leading medical device manufacturers and installed enterprise-wide solutions in over 1,650 hospitals in 37 countries. For more information, visit http://www.capsuletech.com or call +1 978-482-2337 (US), or +33 1 84 17 12 00 (France).


Contact